Ganeden Claims “Highest Level” Proof For Anti-Aging Probiotic
This article was originally published in The Tan Sheet
Ganeden Biotech is optimistic that evidence backing the efficacy of its anti-aging probiotic Bonicel will drive success of the branded ingredient. As regulators and lawsuits target cosmetics companies over claims, science that can withstand these tests becomes more important.
You may also be interested in...
Consumer lawsuit seeking class-action certification faults the Estee Lauder Companies for scientific language in its Clinique marketing that implies FDA approval, and for performance claims that can’t be true or they’d render the product a drug. Plaintiff’s lawyer says anti-aging marketers are “pushing the envelope.”
European industry trade associations file a lawsuit to block the implementation of what they call EFSA’s restrictive list of permitted health claims. The groups demand the annulment of the general function claim list and ask the EC to “correct the flaws in its approach.”
Research on probiotics’ health benefits rapidly grows, but turning studies into label claims lags due to differences between industry, NIH and FDA about standards for claims substantiation. Attendees at a U.S. Pharmacopeia conference outline the challenges to finding common ground